Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | HRH2 | P25021 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19074420 | 1.00 | HRH3 (0.39) | HRH3MAOBALDH1A1LTA4HHRH2 | |
| SCHEMBL12371259 | 0.89 | HTR1A (0.36) | HRH3MAOBALDH1A1HRH2HRH1 | |
| SCHEMBL12841670 | 0.89 | HTR1A (0.36) | HRH3MAOBALDH1A1HRH2HRH1 | |
| SCHEMBL14406225 | 0.85 | HRH3 (0.44) | HRH3MAOBLTA4HHRH2HRH1 | |
| SCHEMBL16596865 | 0.83 | HRH3 (0.43) | HRH3MAOBHRH2HRH1 | |
| SCHEMBL31094669 | 0.81 | EBP (0.42) | HRH3MAOBHRH2HRH1 | |
| SCHEMBL16596870 | 0.81 | EBP (0.42) | HRH3MAOBHRH2HRH1 | |
| SCHEMBL29564435 | 0.81 | EBP (0.42) | HRH3MAOBHRH2HRH1 | |
| SCHEMBL19275137 | 0.81 | EBP (0.42) | HRH3MAOBHRH2HRH1 | |
| SCHEMBL11587019 | 0.81 | EBP (0.42) | HRH3MAOBHRH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110510635-A | A kind of Cu-SSZ-39 molecular sieve and its preparation method and application | RES CT FOR ECO ENVIRONMENTAL SCIENCES CAS | 2019-11-29 | — | — | CN | claimed |
| CN-106745031-B | A kind of high silica alumina ratio SSZ-39 zeolite and its synthesis and application | 中海亚环保材料有限公司 | 2019-05-10 | — | — | CN | claimed |
| CN-106622359-B | A kind of SSZ-39/ZSM-5 composite molecular screen and its synthetic method and application | 中触媒新材料股份有限公司 | 2019-03-08 | — | — | CN | claimed |
| CN-106745057-B | The AEI/MFI eutectics Si-Al molecular sieve and synthetic method of a kind of binder free and application | 中触媒新材料股份有限公司 | 2018-11-13 | — | — | CN | claimed |
| EP-3286163-A1 | METHOD FOR PREPARING STRUCTURED DIRECTING AGENT | Johnson Matthey Public Limited Company (GB) | 2018-02-28 | — | — | EP | claimed |
| US-20180016231-A9 | METHOD FOR PREPARING STRUCTURED DIRECTING AGENT | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2018-01-18 | — | — | US | claimed |
| WO-2016172128-A1 | METHOD FOR PREPARING STRUCTURED DIRECTING AGENT | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2016-10-27 | — | — | WO | claimed |
| US-20160304457-A1 | METHOD FOR PREPARING STRUCTURED DIRECTING AGENT | JOHNSON MATTHEY PLC (GB) | 2016-10-20 | — | — | US | claimed |
| CN-116574050-A | Method for producing structure-directing agents | 庄信万丰股份有限公司 | 2023-08-11 | — | — | CN | disclosed |
| WO-2020223306-A1 | PIM KINASE INHIBITOR COMPOSITIONS AND USES THEREOF | SNAP BIO, INC. (US) | 2020-11-05 | — | — | WO | disclosed |
| CN-110510635-A | A kind of Cu-SSZ-39 molecular sieve and its preparation method and application | RES CT FOR ECO ENVIRONMENTAL SCIENCES CAS | 2019-11-29 | — | — | CN | disclosed |
| CN-110467200-A | A kind of Cu-SSZ-39 molecular sieve and its preparation method and application | RES CT FOR ECO ENVIRONMENTAL SCIENCES CAS | 2019-11-19 | — | — | CN | disclosed |
| CN-110392607-A | Transition metal-supported zeolite, method for producing same, catalyst for nitrogen oxide purification, and method for using same | 三菱化学株式会社 | 2019-10-29 | — | — | CN | disclosed |
| CN-107074569-B | AEI-type zeolites, methods of making, and uses thereof | 三菱化学株式会社 | 2019-09-13 | — | — | CN | disclosed |
| WO-2008012413-A2 | PYRIMIDINONE DERIVATIVES AND THEIR USE AS A DRUG | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUE (S.C.R.A.S.) (FR) | 2008-01-31 | — | — | WO | disclosed |
| WO-2006077424-A1 | PHARMACEUTICAL COMPOUNDS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-07-27 | — | — | WO | disclosed |
| WO-2006077428-A1 | PHARMACEUTICAL COMPOUNDS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-07-27 | — | — | WO | disclosed |
| WO-2006077414-A1 | PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDK' S AND GSK' S | ASTEX THERAPEUTICS LIMITED (GB) | 2006-07-27 | — | — | WO | disclosed |
| WO-2006077425-A1 | COMBINATIONS OF PYRAZOLE KINASE INHIBITORS AND FURTHER ANTITUMOR AGENTS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-07-27 | — | — | WO | disclosed |
| WO-2005012256-A1 | 3, 4-DISUBSTITUTED 1H-PYRAZOLE COMPOUNDS AND THEIR USE AS CYCLIN DEPENDENT KINASES (CDK) AND GLYCOGEN SYNTHASE KINASE-3 (GSK-3) MODULATORS | ASTEX THERAPEUTICS LIMITED (GB) | 2005-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180016231-A9 | METHOD FOR PREPARING STRUCTURED DIRECTING AGENT | SDAD1, ARSA, STS | HRH3 1783/4885MAOB 3483/4885ALDH1A1 1839/4885 |
| US-20160304457-A1 | METHOD FOR PREPARING STRUCTURED DIRECTING AGENT | SDAD1, ARSA, STS | HRH3 1783/4885MAOB 3483/4885ALDH1A1 1839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.